[1]
Mushtaq, J. et al. 2026. A Comprehensive Single-Center Analysis of Subcutaneous Infliximab in the Management of Inflammatory Bowel Disease, Lahore Pakistan. Pakistan Journal of Gastroenterology. 42, 1 (May 2026), 869–882. DOI:https://doi.org/10.63521/pjg.42.1.2026.77.